Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia.
Humans
Leukemia, Myeloid, Acute
/ drug therapy
Tretinoin
/ pharmacology
Systems Biology
/ methods
HL-60 Cells
Gene Expression Profiling
K562 Cells
Drug Discovery
/ methods
Transcriptome
Cell Line, Tumor
Cyclin-Dependent Kinase 6
/ metabolism
Antineoplastic Agents
/ pharmacology
Gene Expression Regulation, Leukemic
/ drug effects
Tumor Necrosis Factor-alpha
/ metabolism
HL-60
K562
NB4
acute myeloid leukemia
all-trans-retinoic acid
granulocytic differentiation
proteome
transcriptome
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Apr 2024
23 Apr 2024
Historique:
received:
27
03
2024
revised:
18
04
2024
accepted:
20
04
2024
medline:
11
5
2024
pubmed:
11
5
2024
entrez:
11
5
2024
Statut:
epublish
Résumé
Combining new therapeutics with all-
Identifiants
pubmed: 38731835
pii: ijms25094618
doi: 10.3390/ijms25094618
pii:
doi:
Substances chimiques
Tretinoin
5688UTC01R
Cyclin-Dependent Kinase 6
EC 2.7.11.22
Antineoplastic Agents
0
Tumor Necrosis Factor-alpha
0
CDK6 protein, human
EC 2.7.11.22
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Russian Science Foundation
ID : 21-74-20122